Neuronetics sees FY25 revenue $145M-$155M

For fiscal year 2025, Neuronetics (STIM) expects: Gross margin: approximately 55%; Operating expenses: $90.0 million to $98.0 million. The Company anticipates reduced cash burn in the first half of 2025, with plans to be cash flow positive beginning in the third quarter. The Company will provide additional guidance during its fourth quarter earnings call.